Bank of New York Mellon’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $8.58K | Sell |
|
|||||
|
2023
Q1 | $15.7K | Sell |
|
|||||
|
2022
Q4 | $19.4K | Sell |
|
|||||
|
2022
Q3 | $27K | Buy |
|
|||||
|
2022
Q2 | $42K | Sell |
|
|||||
|
2022
Q1 | $75K | Hold |
|
|||||
|
2021
Q4 | $106K | Hold |
|
|||||
|
2021
Q3 | $156K | Buy |
|
|||||
|
2021
Q2 | $104K | Sell |
|
|||||
|
2021
Q1 | $100K | Sell |
|
|||||
|
2020
Q4 | $77K | Buy |
|
|||||
|
2020
Q3 | $34K | Buy |
|
|||||
|
2020
Q2 | $34K | Sell |
|
|||||
|
2020
Q1 | $243K | Sell |
|
|||||
|
2019
Q4 | $411K | Buy |
|
|||||
|
2019
Q3 | $464K | Buy |
|
|||||
|
2019
Q2 | $789K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $290K | Buy |
|
|||||
|
2017
Q4 | $398K | Sell |
|
|||||
|
2017
Q3 | $301K | Buy |
|
|||||
|
2017
Q2 | $602K | Buy |
|
|||||
|
2017
Q1 | $245K | Buy |
|
|||||
|
2016
Q4 | $180K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $69K | Buy |
|